Jeffrey Manese
Physician Assistant · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: 057003 · California Pacific Medical Center- Van Ness Campus · California Pacific Medical Ctr-Davies Campus Hosp. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Jeffrey Manese’s office at (415) 600-1020 to ask if they take your plan before you enroll.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- California Pacific Medical Ctr-Davies Campus HospSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.187, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for California Pacific Medical Ctr-Davies Campus Hosp
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.187 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 232 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.56 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 257 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 721 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 2,031 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.45) · 2,032 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.35 (0.94 to 5.76) · 419 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.44) · 414 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.95 (2.91 to 20.98) · 218 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (1.47 to 9.75) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 1,461 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 58 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.756 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 65.3 · 84 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.6 · 115 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 25 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 312 cases | No different | Jan 2024 – Dec 2024 |
What patients said (602 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$36,436
Medicare paid this office $36,436 for 179 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 142 | $27,508 | $130 |
| Return visit (30+ min) | 39 | $4,650 | $97 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 89 | $1,231 | $13 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 14 | $325 | $23 |
Who their Medicare patients are
179 Original Medicare patients in 2024. Average age 78 · Women 44% · Also on Medicaid 20% · Health risk score 1.55. Above the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 73% · Depression 39% · Diabetes 30% · Coronary heart disease 23% · Chronic kidney disease 23% · Dementia 21% · Atrial fibrillation 17% · Cancer 14% · Heart failure 11% · Stroke 9% · COPD 8%.
The office billed $146,401, Medicare allowed $49,907 and paid $36,436; for 409 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 179 | 409 | 78 | 1.55 | $146,401 | $36,436 |
| 2023 | 218 | 404 | 77 | 1.50 | $172,099 | $45,006 |
| 2022 | 177 | 319 | 75 | 1.47 | $100,022 | $28,410 |
| 2021 | 111 | 298 | 71 | 0.90 | $70,467 | $19,783 |
| 2020 | 39 | 53 | 70 | 0.96 | $10,991 | $3,066 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Long return visit (40+ min) | 166 | $30,811 | $133 |
| Return visit (30+ min) | 89 | $8,920 | $86 |
| New patient visit (60+ min) | 11 | $1,768 | $161 |
| Short return visit (20+ min) | 17 | $1,336 | $74 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 18 | $525 | $25 |
2022: 7 services
| Long return visit (40+ min) | 72 | $12,417 | $143 |
| Return visit (30+ min) | 41 | $4,870 | $85 |
| Short return visit (20+ min) | 48 | $2,952 | $50 |
| Telephone medical discussion with physician, 11-20 minutes | 20 | $1,427 | $71 |
| Short return visit | 14 | $656 | $47 |
| Telephone medical discussion with physician, 5-10 minutes | 11 | $550 | $46 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 12 | $303 | $25 |
2021: 6 services
| Return visit (30+ min) | 47 | $6,806 | $83 |
| Short return visit (20+ min) | 55 | $5,287 | $62 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 19 | $2,532 | $133 |
| Influenza vaccine split virus, preservative free | 13 | $848 | $65 |
| Short return visit | 13 | $437 | $31 |
| Administration of influenza virus vaccine | 15 | $267 | $18 |
2020: 1 service
| Short return visit (20+ min) | 25 | $1,382 | $53 |
Drugs they prescribed that Part D paid
$956,017
Pharmacies billed $956,017 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,009) in 2024. At or below the middle of the specialty; the typical physician assistant clinician is at 1%.
1,565 generic and 444 brand-name prescriptions · $956,017 in drug cost · 32 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ingrezza | None | 43 | $325,956 | $7,580 |
| Rytary | Parkinson's | 196 | $228,699 | $1,167 |
| Inbrija | None | 45 | $162,263 | $3,606 |
| Ongentys | None | 51 | $40,365 | $791 |
| Carbidopa-Levodopa Er | None | 354 | $34,251 | $97 |
See all 28 drugs
| Ingrezza | None | 43 | $325,956 | $7,580 |
| Rytary | Parkinson's | 196 | $228,699 | $1,167 |
| Inbrija | None | 45 | $162,263 | $3,606 |
| Ongentys | None | 51 | $40,365 | $791 |
| Carbidopa-Levodopa Er | None | 354 | $34,251 | $97 |
| Carbidopa-Levodopa | None | 385 | $21,305 | $55 |
| Xadago | None | 13 | $18,947 | $1,457 |
| Neupro | None | 15 | $15,194 | $1,013 |
| Droxidopa | None | 20 | $15,182 | $759 |
| Rasagiline Mesylate | None | 73 | $13,681 | $187 |
| Entacapone | None | 36 | $7,435 | $207 |
| Carbidopa | None | 16 | $6,592 | $412 |
| Selegiline | None | 42 | $2,880 | $69 |
| Amantadine | None | 43 | $2,147 | $50 |
| Donepezil | None | 112 | $1,389 | $12 |
| Quetiapine | None | 30 | $1,287 | $43 |
| Gabapentin | None | 59 | $905 | $15 |
| Rivastigmine | None | 13 | $852 | $66 |
| Pramipexole Dihydrochloride | None | 60 | $851 | $14 |
| Memantine | None | 27 | $710 | $26 |
| Propranolol | None | 46 | $596 | $13 |
| Escitalopram | None | 53 | $575 | $11 |
| Mirtazapine | None | 17 | $515 | $30 |
| Pregabalin | None | 30 | $431 | $14 |
| Bupropion | None | 13 | $383 | $29 |
| Trazodone | None | 20 | $240 | $12 |
| Bupropion Xl | None | 15 | $140 | $9 |
| Diazepam | None | 11 | $32 | $3 |
Year by year
| 2024 | 2,009 | 311 | 0% (0) | 22% | $956,017 |
| 2023 | 2,206 | 343 | 0% (0) | 21% | $1,171,476 |
| 2022 | 2,783 | 339 | 1% (33) | None | $1,302,651 |
| 2021 | 3,415 | 221 | 3% (104) | None | $1,469,557 |
| 2020 | 3,750 | 274 | 4% (131) | None | $1,629,266 |
| 2019 | 3,022 | 300 | 2% (48) | None | $1,407,075 |
| 2018 | 2,560 | 208 | 2% (53) | None | $975,046 |
| 2017 | 1,693 | 106 | None | None | $690,773 |
| 2016 | 1,369 | 75 | None | 29% | $440,999 |
| 2015 | 1,026 | 59 | None | None | $454,203 |
| 2014 | 1,222 | 60 | None | None | $408,111 |
| 2013 | 877 | 60 | 1% (12) | 42% | $284,707 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 37 drugs
| Ingrezza | None | 50 | $385,312 | $7,706 |
| Rytary | Parkinson's | 168 | $232,442 | $1,384 |
| Inbrija | None | 21 | $109,816 | $5,229 |
| Ongentys | None | 71 | $56,617 | $797 |
| Biktarvy | None | 12 | $49,200 | $4,100 |
| Gocovri | None | 11 | $36,511 | $3,319 |
| Carbidopa-Levodopa Er | None | 277 | $36,149 | $131 |
| Carbidopa-Levodopa | None | 461 | $35,631 | $77 |
| Rasagiline Mesylate | None | 72 | $20,290 | $282 |
| Xadago | None | 12 | $15,269 | $1,272 |
| Entacapone | None | 31 | $7,936 | $256 |
| Carbidopa | None | 13 | $6,372 | $490 |
| Belsomra | None | 12 | $4,976 | $415 |
| Selegiline | None | 39 | $4,663 | $120 |
| Pregabalin | None | 42 | $3,152 | $75 |
| Quetiapine | None | 63 | $3,045 | $48 |
| Memantine | None | 33 | $1,827 | $55 |
| Donepezil | None | 99 | $1,352 | $14 |
| Propranolol | None | 38 | $1,312 | $35 |
| Ropinirole | None | 15 | $858 | $57 |
| Gabapentin | None | 40 | $853 | $21 |
| Escitalopram | None | 45 | $751 | $17 |
| Amantadine | None | 12 | $593 | $49 |
| Tamsulosin | None | 17 | $590 | $35 |
| Pramipexole Dihydrochloride | None | 48 | $543 | $11 |
| Rosuvastatin | None | 14 | $463 | $33 |
| Mirtazapine | None | 14 | $425 | $30 |
| Atorvastatin | None | 33 | $399 | $12 |
| Trazodone | None | 15 | $339 | $23 |
| Baclofen | None | 16 | $314 | $20 |
| Amlodipine Besylate | None | 16 | $194 | $12 |
| Losartan | None | 12 | $155 | $13 |
| Alprazolam | None | 13 | $146 | $11 |
| Lisinopril | None | 16 | $100 | $6 |
| Lacosamide | None | 11 | $88 | $8 |
| Sertraline | None | 16 | $88 | $6 |
| Pantoprazole | None | 11 | $83 | $8 |
2022: 70 drugs
| Biktarvy | None | 50 | $189,753 | $3,795 |
| Tivicay | None | 61 | $130,399 | $2,138 |
| Descovy | None | 47 | $105,717 | $2,249 |
| Ingrezza | None | 14 | $102,142 | $7,296 |
| Prezcobix | None | 39 | $92,773 | $2,379 |
| Dovato | None | 19 | $67,247 | $3,539 |
| Rytary | Parkinson's | 42 | $50,483 | $1,202 |
| Triumeq | None | 14 | $49,835 | $3,560 |
| Odefsey | None | 12 | $42,270 | $3,522 |
| Edurant | None | 21 | $28,374 | $1,351 |
| Eliquis | None | 21 | $21,022 | $1,001 |
| Trulicity | None | 12 | $16,182 | $1,349 |
| Ongentys | None | 20 | $13,673 | $684 |
| Carbidopa-Levodopa | None | 152 | $10,099 | $66 |
| Atazanavir Sulfate | None | 13 | $9,170 | $705 |
| Spiriva Handihaler | None | 13 | $8,752 | $673 |
| Carbidopa-Levodopa Er | None | 78 | $8,714 | $112 |
| Rasagiline Mesylate | None | 18 | $6,018 | $334 |
| Dexilant | None | 13 | $4,294 | $330 |
| Dutasteride | None | 17 | $2,815 | $166 |
| Atorvastatin | None | 161 | $2,252 | $14 |
| Valacyclovir | None | 25 | $1,554 | $62 |
| Tamsulosin | None | 59 | $1,505 | $26 |
| Pregabalin | None | 22 | $1,175 | $53 |
| Memantine | None | 12 | $1,037 | $86 |
| Rosuvastatin | None | 47 | $971 | $21 |
| Losartan | None | 61 | $827 | $14 |
| Bupropion Hcl Sr | None | 24 | $683 | $28 |
| Donepezil | None | 39 | $682 | $17 |
| Pramipexole Dihydrochloride | None | 19 | $643 | $34 |
| Finasteride | None | 31 | $621 | $20 |
| Lisinopril | None | 77 | $619 | $8 |
| Gabapentin | None | 38 | $614 | $16 |
| Amlodipine Besylate | None | 91 | $570 | $6 |
| Montelukast | None | 28 | $539 | $19 |
| Escitalopram | None | 43 | $485 | $11 |
| Fluticasone Propionate | None | 13 | $465 | $36 |
| Fenofibrate | None | 20 | $463 | $23 |
| Omeprazole | None | 40 | $443 | $11 |
| Propranolol | None | 24 | $434 | $18 |
| Levothyroxine | None | 20 | $426 | $21 |
| Allopurinol | None | 30 | $415 | $14 |
| Famotidine | None | 20 | $378 | $19 |
| Fluoxetine | None | 28 | $352 | $13 |
| Bupropion Xl | None | 16 | $342 | $21 |
| Acyclovir | None | 25 | $338 | $14 |
| Sertraline | None | 21 | $268 | $13 |
| Trazodone | None | 34 | $265 | $8 |
| Amiloride | None | 11 | $264 | $24 |
| Baclofen | None | 17 | $247 | $15 |
| Hydrochlorothiazide | None | 45 | $244 | $5 |
| Metformin | None | 31 | $237 | $8 |
| Pantoprazole | None | 20 | $232 | $12 |
| Hydrocodone-Acetaminophen | None | 21 | $230 | $11 |
| Metoprolol | None | 13 | $228 | $18 |
| Lorazepam | None | 32 | $205 | $6 |
| Lisinopril-Hydrochlorothiazide | None | 11 | $200 | $18 |
| Temazepam | None | 12 | $189 | $16 |
| Simvastatin | None | 26 | $184 | $7 |
| Pravastatin | None | 11 | $150 | $14 |
| Zolpidem | None | 17 | $148 | $9 |
| Amitriptyline | None | 16 | $137 | $9 |
| Clotrimazole | None | 12 | $121 | $10 |
| Quetiapine | None | 15 | $119 | $8 |
| Alprazolam | None | 21 | $117 | $6 |
| Mupirocin | None | 13 | $109 | $8 |
| Benazepril | None | 16 | $104 | $6 |
| Ibuprofen | None | 11 | $82 | $7 |
| Clonazepam | None | 17 | $64 | $4 |
| Metoprolol | None | 20 | $60 | $3 |
2021: 87 drugs
| Descovy | 85 | $193,067 | $2,271 |
| Tivicay | 76 | $153,281 | $2,017 |
| Biktarvy | 37 | $129,713 | $3,506 |
| Dovato | 36 | $119,102 | $3,308 |
| Prezcobix | 33 | $73,565 | $2,229 |
| Symtuza | 16 | $68,203 | $4,263 |
| Odefsey | 21 | $67,903 | $3,233 |
| Genvoya | 17 | $60,382 | $3,552 |
| Triumeq | 17 | $56,647 | $3,332 |
| Juluca | 16 | $50,043 | $3,128 |
| Prezista | 20 | $38,763 | $1,938 |
| Isentress | 20 | $36,903 | $1,845 |
| Selzentry | 22 | $36,316 | $1,651 |
| Edurant | 26 | $33,450 | $1,287 |
| Efavirenz-Emtric-Tenofov Disop | 13 | $26,695 | $2,053 |
| Isentress Hd | 12 | $21,864 | $1,822 |
| Eliquis | 22 | $21,782 | $990 |
| Emtricitabine-Tenofovir Disop | 24 | $19,347 | $806 |
| Evotaz | 11 | $18,755 | $1,705 |
| Trulicity | 12 | $17,475 | $1,456 |
| Xarelto | 12 | $15,938 | $1,328 |
| Symbicort | 11 | $12,168 | $1,106 |
| Spiriva | 15 | $10,589 | $706 |
| Nevirapine Er | 14 | $7,256 | $518 |
| Testosterone | 20 | $6,749 | $337 |
| Dexilant | 18 | $6,748 | $375 |
| Atorvastatin | 180 | $2,792 | $16 |
| Atazanavir Sulfate | 11 | $2,317 | $211 |
| Valacyclovir | 34 | $2,187 | $64 |
| Ramelteon | 13 | $1,894 | $146 |
| Tamsulosin | 74 | $1,689 | $23 |
| Alfuzosin Hcl Er | 14 | $1,234 | $88 |
| Dutasteride | 20 | $1,197 | $60 |
| Losartan | 61 | $1,136 | $19 |
| Bupropion Xl | 45 | $1,118 | $25 |
| Ventolin Hfa | 19 | $1,111 | $58 |
| Diclofenac | 34 | $1,072 | $32 |
| Finasteride | 44 | $1,060 | $24 |
| Rosuvastatin | 52 | $1,036 | $20 |
| Gabapentin | 71 | $1,023 | $14 |
| Lisinopril | 109 | $989 | $9 |
| Acyclovir | 44 | $946 | $21 |
| Hydrocodone-Acetaminophen | 62 | $935 | $15 |
| Montelukast | 38 | $817 | $22 |
| Bupropion Hcl Sr | 18 | $762 | $42 |
| Amlodipine Besylate | 89 | $706 | $8 |
| Allopurinol | 44 | $667 | $15 |
| Cyclobenzaprine | 27 | $637 | $24 |
| Quinapril | 16 | $591 | $37 |
| Metformin | 76 | $563 | $7 |
| Levothyroxine | 26 | $562 | $22 |
| Zolpidem | 59 | $514 | $9 |
| Famotidine | 41 | $493 | $12 |
| Omeprazole | 42 | $491 | $12 |
| Lorazepam | 86 | $454 | $5 |
| Escitalopram | 36 | $453 | $13 |
| Fluticasone Propionate | 18 | $450 | $25 |
| Sertraline | 22 | $415 | $19 |
| Piroxicam | 12 | $375 | $31 |
| Celecoxib | 18 | $365 | $20 |
| Fluoxetine | 40 | $356 | $9 |
| Lisinopril-Hydrochlorothiazide | 18 | $342 | $19 |
| Amitriptyline | 19 | $328 | $17 |
| Trazodone | 45 | $326 | $7 |
| Mometasone Furoate | 14 | $319 | $23 |
| Fenofibrate | 18 | $315 | $18 |
| Pantoprazole | 18 | $299 | $17 |
| Pravastatin | 19 | $298 | $16 |
| Metoprolol | 13 | $297 | $23 |
| Ketoconazole | 17 | $280 | $16 |
| Donepezil | 18 | $275 | $15 |
| Baclofen | 26 | $271 | $10 |
| Hydrochlorothiazide | 52 | $251 | $5 |
| Alprazolam | 52 | $229 | $4 |
| Ibuprofen | 18 | $224 | $12 |
| Propranolol | 14 | $223 | $16 |
| Metformin Hcl Er | 14 | $222 | $16 |
| Simvastatin | 36 | $214 | $6 |
| Amlodipine Besylate-Benazepril | 19 | $208 | $11 |
| Sumatriptan | 12 | $206 | $17 |
| Tramadol | 25 | $184 | $7 |
| Temazepam | 20 | $177 | $9 |
| Naproxen | 22 | $169 | $8 |
| Sulfamethoxazole-Trimethoprim | 14 | $151 | $11 |
| Metoprolol | 22 | $118 | $5 |
| Diazepam | 23 | $112 | $5 |
| Clonazepam | 20 | $99 | $5 |
2020: 98 drugs
| Descovy | 88 | $202,041 | $2,296 |
| Tivicay | 85 | $173,238 | $2,038 |
| Biktarvy | 47 | $157,064 | $3,342 |
| Triumeq | 43 | $139,615 | $3,247 |
| Odefsey | 29 | $87,376 | $3,013 |
| Dovato | 32 | $84,900 | $2,653 |
| Prezcobix | 35 | $73,524 | $2,101 |
| Symtuza | 13 | $53,068 | $4,082 |
| Juluca | 18 | $52,257 | $2,903 |
| Genvoya | 16 | $52,201 | $3,263 |
| Isentress | 20 | $47,819 | $2,391 |
| Truvada | 21 | $37,352 | $1,779 |
| Eliquis | 54 | $37,051 | $686 |
| Edurant | 22 | $28,969 | $1,317 |
| Intelence | 19 | $27,206 | $1,432 |
| Spiriva | 25 | $21,776 | $871 |
| Evotaz | 12 | $19,934 | $1,661 |
| Geodon | 12 | $18,517 | $1,543 |
| Xarelto | 18 | $12,667 | $704 |
| Symbicort | 21 | $11,787 | $561 |
| Testosterone | 29 | $10,195 | $352 |
| Nevirapine Er | 19 | $8,928 | $470 |
| Dexilant | 18 | $5,830 | $324 |
| Chantix | 12 | $5,827 | $486 |
| Atorvastatin | 195 | $3,014 | $15 |
| Valacyclovir | 45 | $2,308 | $51 |
| Ramelteon | 11 | $1,953 | $178 |
| Mometasone Furoate | 19 | $1,774 | $93 |
| Bupropion Xl | 50 | $1,629 | $33 |
| Tamsulosin | 64 | $1,458 | $23 |
| Gabapentin | 84 | $1,419 | $17 |
| Rosuvastatin | 47 | $1,363 | $29 |
| Ventolin Hfa | 23 | $1,288 | $56 |
| Dutasteride | 19 | $1,225 | $64 |
| Acyclovir | 57 | $1,161 | $20 |
| Lisinopril | 115 | $1,144 | $10 |
| Finasteride | 57 | $1,134 | $20 |
| Fluoxetine | 41 | $1,080 | $26 |
| Azelastine | 15 | $1,059 | $71 |
| Hydrocodone-Acetaminophen | 72 | $964 | $13 |
| Losartan | 50 | $866 | $17 |
| Levothyroxine | 32 | $813 | $25 |
| Montelukast | 51 | $811 | $16 |
| Ezetimibe | 11 | $717 | $65 |
| Albuterol Sulfate Hfa | 11 | $631 | $57 |
| Metformin | 65 | $621 | $10 |
| Zolpidem | 76 | $604 | $8 |
| Lorazepam | 78 | $600 | $8 |
| Alfuzosin Hcl Er | 12 | $595 | $50 |
| Clotrimazole | 19 | $590 | $31 |
| Fluticasone Propionate | 34 | $536 | $16 |
| Escitalopram | 41 | $530 | $13 |
| Omeprazole | 40 | $512 | $13 |
| Amitriptyline | 25 | $505 | $20 |
| Amlodipine Besylate | 88 | $484 | $5 |
| Lisinopril-Hydrochlorothiazide | 20 | $483 | $24 |
| Celecoxib | 13 | $482 | $37 |
| Quinapril | 12 | $477 | $40 |
| Mirtazapine | 20 | $455 | $23 |
| Sertraline | 33 | $448 | $14 |
| Allopurinol | 45 | $439 | $10 |
| Triamcinolone Acetonide | 14 | $432 | $31 |
| Ketoconazole | 18 | $400 | $22 |
| Alprazolam | 65 | $395 | $6 |
| Cyclobenzaprine | 22 | $386 | $18 |
| Pravastatin | 27 | $379 | $14 |
| Simvastatin | 44 | $377 | $9 |
| Losartan-Hydrochlorothiazide | 13 | $354 | $27 |
| Glipizide Er | 15 | $330 | $22 |
| Diclofenac | 15 | $325 | $22 |
| Baclofen | 20 | $315 | $16 |
| Ibuprofen | 21 | $286 | $14 |
| Eszopiclone | 17 | $278 | $16 |
| Trazodone | 36 | $274 | $8 |
| Metoprolol | 15 | $273 | $18 |
| Fenofibrate | 16 | $246 | $15 |
| Propranolol | 13 | $239 | $18 |
| Quetiapine | 16 | $236 | $15 |
| Tramadol | 27 | $226 | $8 |
| Temazepam | 30 | $223 | $7 |
| Oxycodone | 13 | $212 | $16 |
| Pramipexole Dihydrochloride | 15 | $205 | $14 |
| Piroxicam | 13 | $192 | $15 |
| Pantoprazole | 17 | $192 | $11 |
| Benazepril | 18 | $187 | $10 |
| Hydrochlorothiazide | 51 | $179 | $4 |
| Famotidine | 14 | $179 | $13 |
| Ciclopirox | 13 | $175 | $13 |
| Paroxetine | 18 | $171 | $9 |
| Amiloride | 12 | $139 | $12 |
| Sulfamethoxazole-Trimethoprim | 14 | $128 | $9 |
| Clonazepam | 17 | $124 | $7 |
| Mupirocin | 17 | $117 | $7 |
| Furosemide | 19 | $117 | $6 |
| Naproxen | 21 | $110 | $5 |
| Diazepam | 18 | $83 | $5 |
| Ciprofloxacin | 13 | $65 | $5 |
| Metoprolol | 14 | $30 | $2 |
2019: 78 drugs
| Tivicay | 107 | $217,506 | $2,033 |
| Descovy | 79 | $151,773 | $1,921 |
| Triumeq | 32 | $119,826 | $3,745 |
| Odefsey | 42 | $119,517 | $2,846 |
| Prezcobix | 39 | $77,380 | $1,984 |
| Truvada | 36 | $70,407 | $1,956 |
| Genvoya | 18 | $58,220 | $3,234 |
| Juluca | 21 | $57,441 | $2,735 |
| Biktarvy | 16 | $51,514 | $3,220 |
| Edurant | 37 | $43,843 | $1,185 |
| Isentress | 15 | $36,176 | $2,412 |
| Atripla | 12 | $33,362 | $2,780 |
| Evotaz | 17 | $27,581 | $1,622 |
| Spiriva | 35 | $24,284 | $694 |
| Eliquis | 30 | $15,567 | $519 |
| Xarelto | 21 | $15,431 | $735 |
| Nevirapine Er | 33 | $14,839 | $450 |
| Geodon | 11 | $14,770 | $1,343 |
| Testosterone | 26 | $13,046 | $502 |
| Symbicort | 20 | $11,973 | $599 |
| Chantix | 12 | $5,704 | $475 |
| Dexilant | 15 | $5,077 | $338 |
| Tadalafil | 15 | $4,349 | $290 |
| Atorvastatin | 176 | $3,158 | $18 |
| Dutasteride | 11 | $2,476 | $225 |
| Ventolin Hfa | 35 | $2,110 | $60 |
| Bupropion Xl | 24 | $1,823 | $76 |
| Valacyclovir | 46 | $1,627 | $35 |
| Testosterone Cypionate | 13 | $1,156 | $89 |
| Tamsulosin | 55 | $1,131 | $21 |
| Gabapentin | 62 | $988 | $16 |
| Finasteride | 40 | $777 | $19 |
| Lisinopril | 91 | $756 | $8 |
| Acyclovir | 31 | $734 | $24 |
| Levothyroxine | 28 | $713 | $25 |
| Rosuvastatin | 27 | $707 | $26 |
| Chlorthalidone | 20 | $680 | $34 |
| Losartan | 43 | $669 | $16 |
| Lisinopril-Hydrochlorothiazide | 20 | $610 | $30 |
| Quinapril | 16 | $606 | $38 |
| Metformin | 75 | $564 | $8 |
| Pravastatin | 26 | $557 | $21 |
| Zolpidem | 56 | $552 | $10 |
| Fluoxetine | 34 | $523 | $15 |
| Metoprolol | 23 | $514 | $22 |
| Fluticasone Propionate | 31 | $478 | $15 |
| Mirtazapine | 26 | $467 | $18 |
| Glipizide Er | 12 | $456 | $38 |
| Allopurinol | 35 | $431 | $12 |
| Fenofibrate | 14 | $426 | $30 |
| Trazodone | 43 | $403 | $9 |
| Sertraline | 26 | $385 | $15 |
| Simvastatin | 50 | $347 | $7 |
| Montelukast | 25 | $340 | $14 |
| Clonazepam | 20 | $308 | $15 |
| Amlodipine Besylate | 47 | $304 | $6 |
| Escitalopram | 27 | $303 | $11 |
| Lorazepam | 35 | $283 | $8 |
| Losartan-Hydrochlorothiazide | 18 | $279 | $16 |
| Omeprazole | 21 | $277 | $13 |
| Alprazolam | 54 | $267 | $5 |
| Eszopiclone | 18 | $240 | $13 |
| Baclofen | 19 | $235 | $12 |
| Ibuprofen | 19 | $222 | $12 |
| Temazepam | 24 | $197 | $8 |
| Famotidine | 14 | $191 | $14 |
| Quetiapine | 14 | $177 | $13 |
| Naproxen | 23 | $162 | $7 |
| Propranolol | 11 | $158 | $14 |
| Tramadol | 25 | $144 | $6 |
| Hydrocodone-Acetaminophen | 18 | $140 | $8 |
| Buspirone | 11 | $130 | $12 |
| Pantoprazole | 15 | $124 | $8 |
| Hydrochlorothiazide | 32 | $122 | $4 |
| Diazepam | 17 | $77 | $5 |
| Divalproex | 12 | $66 | $6 |
| Azithromycin | 12 | $60 | $5 |
| Metoprolol | 16 | $51 | $3 |
2018: 69 drugs
| Triumeq | 34 | $123,886 | $3,644 |
| Descovy | 65 | $109,827 | $1,690 |
| Tivicay | 55 | $105,854 | $1,925 |
| Odefsey | 29 | $79,006 | $2,724 |
| Genvoya | 24 | $75,539 | $3,147 |
| Truvada | 13 | $24,979 | $1,921 |
| Androgel | 23 | $22,181 | $964 |
| Intelence | 17 | $21,873 | $1,287 |
| Edurant | 20 | $21,500 | $1,075 |
| Isentress | 13 | $20,750 | $1,596 |
| Nevirapine Er | 39 | $19,808 | $508 |
| Viread | 13 | $15,766 | $1,213 |
| Abacavir-Lamivudine-Zidovudine | 12 | $15,652 | $1,304 |
| Lantus Solostar | 12 | $14,089 | $1,174 |
| Januvia | 13 | $8,847 | $681 |
| Eliquis | 22 | $8,218 | $374 |
| Megestrol Acetate | 13 | $6,999 | $538 |
| Ritonavir | 14 | $4,134 | $295 |
| Dutasteride | 17 | $3,329 | $196 |
| Atorvastatin | 150 | $2,611 | $17 |
| Theophylline Anhydrous | 13 | $2,355 | $181 |
| Celecoxib | 16 | $1,283 | $80 |
| Ventolin Hfa | 21 | $1,158 | $55 |
| Metoprolol | 11 | $1,067 | $97 |
| Tamsulosin | 40 | $1,025 | $26 |
| Valacyclovir | 20 | $713 | $36 |
| Acyclovir | 46 | $648 | $14 |
| Lisinopril | 84 | $625 | $7 |
| Levothyroxine | 30 | $598 | $20 |
| Finasteride | 24 | $552 | $23 |
| Quinapril | 14 | $522 | $37 |
| Pravastatin | 32 | $497 | $16 |
| Gabapentin | 47 | $494 | $11 |
| Zolpidem | 63 | $487 | $8 |
| Fluoxetine | 47 | $462 | $10 |
| Simvastatin | 62 | $456 | $7 |
| Quetiapine | 20 | $414 | $21 |
| Mirtazapine | 19 | $389 | $20 |
| Alprazolam | 59 | $364 | $6 |
| Glipizide Er | 17 | $346 | $20 |
| Warfarin | 20 | $339 | $17 |
| Metformin | 50 | $330 | $7 |
| Allopurinol | 27 | $309 | $11 |
| Losartan | 33 | $296 | $9 |
| Eszopiclone | 17 | $283 | $17 |
| Chlorthalidone | 11 | $273 | $25 |
| Amlodipine Besylate | 33 | $270 | $8 |
| Amitriptyline | 13 | $269 | $21 |
| Klor-Con 10 | 13 | $252 | $19 |
| Potassium Chloride | 13 | $239 | $18 |
| Montelukast | 20 | $238 | $12 |
| Hydrocodone-Acetaminophen | 23 | $231 | $10 |
| Losartan-Hydrochlorothiazide | 23 | $228 | $10 |
| Trazodone | 34 | $219 | $6 |
| Baclofen | 13 | $213 | $16 |
| Escitalopram | 24 | $206 | $9 |
| Sertraline | 19 | $196 | $10 |
| Fluticasone Propionate | 19 | $193 | $10 |
| Lorazepam | 45 | $178 | $4 |
| Metoprolol | 24 | $161 | $7 |
| Omeprazole | 18 | $127 | $7 |
| Temazepam | 16 | $97 | $6 |
| Clonazepam | 17 | $92 | $5 |
| Ibuprofen | 11 | $89 | $8 |
| Tramadol | 16 | $84 | $5 |
| Azithromycin | 12 | $81 | $7 |
| Paroxetine | 12 | $79 | $7 |
| Hydrochlorothiazide | 24 | $77 | $3 |
| Diazepam | 11 | $48 | $4 |
2017: 52 drugs
| Triumeq | 18 | $82,430 | $4,579 |
| Descovy | 40 | $63,306 | $1,583 |
| Odefsey | 22 | $57,015 | $2,592 |
| Genvoya | 20 | $55,557 | $2,778 |
| Tivicay | 35 | $54,452 | $1,556 |
| Reyataz | 25 | $35,812 | $1,432 |
| Atripla | 13 | $35,205 | $2,708 |
| Prezista | 18 | $27,706 | $1,539 |
| Viread | 27 | $26,041 | $964 |
| Isentress | 16 | $23,795 | $1,487 |
| Truvada | 13 | $20,498 | $1,577 |
| Selzentry | 11 | $20,293 | $1,845 |
| Nevirapine Er | 28 | $14,861 | $531 |
| Intelence | 11 | $13,187 | $1,199 |
| Androgel | 11 | $12,765 | $1,160 |
| Norvir | 37 | $12,661 | $342 |
| Geodon | 11 | $9,847 | $895 |
| Januvia | 14 | $6,010 | $429 |
| Lamivudine | 14 | $2,295 | $164 |
| Atorvastatin | 62 | $1,162 | $19 |
| Tamsulosin | 35 | $804 | $23 |
| Bupropion | 12 | $666 | $56 |
| Testosterone Cypionate | 12 | $658 | $55 |
| Levothyroxine | 25 | $623 | $25 |
| Ventolin Hfa | 11 | $585 | $53 |
| Simvastatin | 48 | $465 | $10 |
| Pravastatin | 27 | $456 | $17 |
| Bupropion Xl | 17 | $386 | $23 |
| Lisinopril | 60 | $354 | $6 |
| Zolpidem | 51 | $329 | $6 |
| Temazepam | 31 | $313 | $10 |
| Acyclovir | 27 | $298 | $11 |
| Finasteride | 17 | $288 | $17 |
| Escitalopram | 35 | $269 | $8 |
| Metoprolol | 12 | $232 | $19 |
| Montelukast | 14 | $218 | $16 |
| Amitriptyline | 11 | $216 | $20 |
| Alprazolam | 42 | $211 | $5 |
| Metformin | 48 | $201 | $4 |
| Sertraline | 17 | $201 | $12 |
| Eszopiclone | 15 | $200 | $13 |
| Warfarin | 13 | $196 | $15 |
| Lorazepam | 40 | $152 | $4 |
| Fluoxetine | 17 | $115 | $7 |
| Amlodipine Besylate | 32 | $99 | $3 |
| Losartan-Hydrochlorothiazide | 15 | $82 | $5 |
| Hydrochlorothiazide | 25 | $74 | $3 |
| Metoprolol | 14 | $66 | $5 |
| Paroxetine | 13 | $59 | $5 |
| Diazepam | 16 | $49 | $3 |
| Clonazepam | 11 | $41 | $4 |
| Cyclobenzaprine | 12 | $31 | $3 |
2016: 44 drugs
| Truvada | 40 | $59,417 | $1,485 |
| Triumeq | 15 | $54,318 | $3,621 |
| Tivicay | 24 | $34,643 | $1,443 |
| Genvoya | 13 | $34,193 | $2,630 |
| Isentress | 22 | $28,356 | $1,289 |
| Reyataz | 19 | $22,983 | $1,210 |
| Prezista | 12 | $16,138 | $1,345 |
| Androgel | 20 | $13,130 | $657 |
| Viread | 19 | $13,104 | $690 |
| Geodon | 17 | $10,299 | $606 |
| Januvia | 23 | $8,412 | $366 |
| Norvir | 17 | $6,218 | $366 |
| Cialis | 23 | $5,904 | $257 |
| Abacavir | 16 | $4,162 | $260 |
| Lamivudine | 13 | $2,706 | $208 |
| Celecoxib | 24 | $1,850 | $77 |
| Dutasteride | 15 | $1,761 | $117 |
| Tamsulosin | 37 | $1,622 | $44 |
| Atorvastatin | 72 | $1,297 | $18 |
| Valacyclovir | 12 | $1,068 | $89 |
| Lopreeza | 12 | $651 | $54 |
| Testosterone Cypionate | 14 | $532 | $38 |
| Zolpidem | 37 | $506 | $14 |
| Levothyroxine | 21 | $497 | $24 |
| Pravastatin | 12 | $459 | $38 |
| Lisinopril | 54 | $322 | $6 |
| Temazepam | 27 | $285 | $11 |
| Finasteride | 18 | $281 | $16 |
| Eszopiclone | 15 | $277 | $18 |
| Alprazolam | 33 | $259 | $8 |
| Simvastatin | 31 | $224 | $7 |
| Allopurinol | 15 | $213 | $14 |
| Metformin | 31 | $201 | $6 |
| Acyclovir | 18 | $199 | $11 |
| Losartan | 29 | $191 | $7 |
| Escitalopram | 22 | $156 | $7 |
| Pantoprazole | 11 | $146 | $13 |
| Lorazepam | 26 | $118 | $5 |
| Ranitidine | 13 | $116 | $9 |
| Triamcinolone Acetonide | 11 | $104 | $9 |
| Trazodone | 16 | $102 | $6 |
| Diazepam | 21 | $75 | $4 |
| Fluoxetine | 13 | $73 | $6 |
| Amlodipine Besylate | 15 | $69 | $5 |
2015: 35 drugs
| Truvada | 35 | $50,710 | $1,449 |
| Isentress | 27 | $32,420 | $1,201 |
| Prezista | 18 | $29,011 | $1,612 |
| Reyataz | 12 | $15,768 | $1,314 |
| Tivicay | 11 | $14,639 | $1,331 |
| Intelence | 11 | $11,277 | $1,025 |
| Viread | 11 | $10,108 | $919 |
| Abacavir | 28 | $9,686 | $346 |
| Norvir | 19 | $8,736 | $460 |
| Januvia | 18 | $6,652 | $370 |
| Geodon | 13 | $6,407 | $493 |
| Lamivudine | 15 | $2,999 | $200 |
| Crestor | 12 | $2,548 | $212 |
| Celecoxib | 16 | $1,845 | $115 |
| Rabeprazole | 12 | $1,618 | $135 |
| Tamsulosin | 27 | $1,308 | $48 |
| Atorvastatin | 44 | $737 | $17 |
| Testosterone Cypionate | 14 | $580 | $41 |
| Montelukast | 14 | $316 | $23 |
| Metformin | 46 | $294 | $6 |
| Zolpidem | 14 | $275 | $20 |
| Cartia Xt | 11 | $261 | $24 |
| Levothyroxine | 17 | $254 | $15 |
| Lisinopril | 44 | $228 | $5 |
| Simvastatin | 27 | $210 | $8 |
| Finasteride | 16 | $208 | $13 |
| Allopurinol | 22 | $195 | $9 |
| Omeprazole | 11 | $188 | $17 |
| Metoprolol | 12 | $172 | $14 |
| Losartan | 18 | $138 | $8 |
| Lisinopril-Hydrochlorothiazide | 26 | $125 | $5 |
| Temazepam | 17 | $100 | $6 |
| Trazodone | 16 | $70 | $4 |
| Alprazolam | 19 | $56 | $3 |
| Hydrochlorothiazide | 11 | $53 | $5 |
2014: 42 drugs
| Truvada | 53 | $61,620 | $1,163 |
| Reyataz | 36 | $43,856 | $1,218 |
| Epzicom | 25 | $34,434 | $1,377 |
| Prezista | 25 | $31,541 | $1,262 |
| Atripla | 13 | $26,841 | $2,065 |
| Lexiva | 11 | $24,451 | $2,223 |
| Isentress | 20 | $22,994 | $1,150 |
| Norvir | 36 | $15,477 | $430 |
| Viread | 29 | $14,610 | $504 |
| Intelence | 12 | $11,608 | $967 |
| Abacavir | 22 | $9,537 | $434 |
| Edurant | 11 | $8,431 | $766 |
| Crestor | 27 | $5,157 | $191 |
| Januvia | 15 | $4,499 | $300 |
| Lamivudine | 32 | $3,308 | $103 |
| Valacyclovir | 24 | $2,180 | $91 |
| Atorvastatin | 72 | $1,853 | $26 |
| Avodart | 11 | $1,568 | $143 |
| Tamsulosin | 31 | $905 | $29 |
| Fenofibrate | 15 | $650 | $43 |
| Metformin | 45 | $487 | $11 |
| Zolpidem Tartrate Er | 12 | $388 | $32 |
| Nevirapine | 11 | $344 | $31 |
| Finasteride | 25 | $306 | $12 |
| Venlafaxine Hcl Er | 11 | $306 | $28 |
| Lisinopril-Hydrochlorothiazide | 38 | $289 | $8 |
| Lisinopril | 45 | $275 | $6 |
| Levothyroxine | 20 | $248 | $12 |
| Omeprazole | 19 | $225 | $12 |
| Simvastatin | 26 | $211 | $8 |
| Metoprolol | 12 | $189 | $16 |
| Methocarbamol | 11 | $180 | $16 |
| Cartia Xt | 12 | $180 | $15 |
| Triamterene-Hydrochlorothiazid | 13 | $134 | $10 |
| Amlodipine Besylate | 18 | $114 | $6 |
| Warfarin | 11 | $89 | $8 |
| Trazodone | 12 | $87 | $7 |
| Sulfamethoxazole-Trimethoprim | 16 | $84 | $5 |
| Escitalopram | 12 | $82 | $7 |
| Ranitidine | 11 | $73 | $7 |
| Alprazolam | 11 | $70 | $6 |
| Allopurinol | 12 | $19 | $2 |
2013: 32 drugs
| Truvada | 47 | $51,234 | $1,090 |
| Epzicom | 33 | $36,976 | $1,120 |
| Atripla | 15 | $28,828 | $1,922 |
| Lexiva | 16 | $28,608 | $1,788 |
| Reyataz | 18 | $20,245 | $1,125 |
| Isentress | 11 | $11,785 | $1,071 |
| Androgel | 19 | $9,619 | $506 |
| Kaletra | 12 | $9,191 | $766 |
| Viread | 19 | $8,667 | $456 |
| Edurant | 12 | $8,524 | $710 |
| Viramune Xr | 13 | $7,990 | $615 |
| Norvir | 14 | $4,702 | $336 |
| Januvia | 13 | $3,376 | $260 |
| Crestor | 13 | $2,253 | $173 |
| Atorvastatin | 59 | $2,089 | $35 |
| Trilipix | 11 | $1,906 | $173 |
| Lamivudine | 19 | $1,402 | $74 |
| Valacyclovir | 14 | $1,189 | $85 |
| Epivir | 12 | $844 | $70 |
| Nevirapine | 12 | $571 | $48 |
| Escitalopram | 13 | $403 | $31 |
| Warfarin | 20 | $395 | $20 |
| Tamsulosin | 22 | $376 | $17 |
| Finasteride | 18 | $358 | $20 |
| Metformin | 17 | $324 | $19 |
| Lisinopril-Hydrochlorothiazide | 26 | $279 | $11 |
| Lisinopril | 40 | $198 | $5 |
| Omeprazole | 17 | $190 | $11 |
| Levothyroxine | 21 | $185 | $9 |
| Ranitidine | 12 | $99 | $8 |
| Temazepam | 13 | $86 | $7 |
| Alprazolam | 11 | $71 | $6 |
Money from drug and device companies
$568 in 2025
| 2025 | 4 | 16 | $26 | $568 |
| 2024 | 9 | 18 | None | $609 |
| 2023 | 3 | 7 | None | $422 |
| 2022 | 4 | 6 | None | $202 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | General - Dbs | $325 | 7 payments
|
| MDD US Operations | None | $176 | 7 payments
|
| Neurocrine BioSciences | Ingrezza | $40 | 1 payment
|
| Abbvie | Vyalev | $27 | 1 payment
|
See all 16 published payments
| Boston Scientific | Meals · 2025-11-04 | Vercise | $32 |
| Abbvie | Meals · 2025-08-19 | Vyalev | $27 |
| MDD US Operations | Paid to speak or teach · 2025-07-09 | None | $26 |
| MDD US Operations | Meals · 2025-06-27 | None | $24 |
| MDD US Operations | Meals · 2025-06-24 | None | $24 |
| Boston Scientific | Meals · 2025-06-03 | General - Dbs | $60 |
| Boston Scientific | Meals · 2025-05-06 | General - Dbs | $45 |
| Boston Scientific | Meals · 2025-04-09 | General - Dbs | $52 |
| Boston Scientific | Meals · 2025-04-01 | General - Dbs | $57 |
| MDD US Operations | Meals · 2025-03-31 | None | $27 |
| Neurocrine BioSciences | Meals · 2025-03-26 | Ingrezza | $40 |
| Boston Scientific | Meals · 2025-03-04 | Vercise | $39 |
| MDD US Operations | Meals · 2025-02-26 | None | $41 |
| MDD US Operations | Meals · 2025-02-12 | None | $24 |
| MDD US Operations | Meals · 2025-02-06 | None | $10 |
| Boston Scientific | Meals · 2025-02-04 | Vercise | $40 |
See earlier years (2024, 2023, 2022)
2024: $609
| Boston Scientific | Vercise | $291 | 7 payments
|
| Neurocrine Biosciences | Ingrezza | $101 | 4 payments
|
| Merz Pharmaceuticals | Xeomin | $49 | 1 payment
|
| Teva Pharmaceuticals USA | Austedo Xr | $34 | 1 payment
|
| Abbvie | Vyalev | $32 | 1 payment
|
| ACADIA Pharmaceuticals | Nuplazid | $28 | 1 payment
|
| Amneal Pharmaceuticals | Crexont | $27 | 1 payment
|
| Abbott Laboratories | Infinity | $24 | 1 payment
|
| Acorda Therapeutics | Inbrija | $24 | 1 payment
|
2023: $422
| Medtronic | Percept PC Brainsense | $274 | 4 payments
|
| Teva Pharmaceuticals USA | None | $85 | 1 payment
|
| Neurocrine Biosciences | Ongentys | $63 | 2 payments
|
2022: $202
| Gilead Sciences | Viread | $125 | 2 payments
|
| Medtronic | Percept PC Brainsense | $47 | 2 payments
|
| Sunovion Pharmaceuticals | Kynmobi | $18 | 1 payment
|
| Impel Pharmaceuticals | Trudhesa | $12 | 1 payment
|
Professional record
- NPI
- 1619023769
- Licence
- CA PA 18366, CA PT20351
- Trained
- Stanford University School of Medicine, 2006
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X); Federal specialty code 225100000X (225100000X)
- Mailing address
- 4333 Fleming Ave, Oakland, CA, 94619
- NPI first listed
- 2007-01-25
- NPI last updated
- 2007-11-17
This is when the NPI record was last certified, not a medical board exam.